Ir al contenido
  • About us
  • Products
    • MED
    • OTC
    • HEALTH
    • INNOVATION
    • ECO
    • Product lines
  • R&D+i
    • Pharma & OTC
    • Advanced Therapies
  • Our plants
    • Madrid
    • Valencia
  • Our purpose
  • News
  • Contact
  • About us
  • Products
    • MED
    • OTC
    • HEALTH
    • INNOVATION
    • ECO
    • Product lines
  • R&D+i
    • Pharma & OTC
    • Advanced Therapies
  • Our plants
    • Madrid
    • Valencia
  • Our purpose
  • News
  • Contact

Farmalider launches “Farmalider ECO”, a new strategic platform for responsible pharmaceutical innovation

abril 8, 2026

Farmalider ECO, the company’s new pharmaceutical innovation platform, prioritizes sustainability across its processes and products, delivering responsible solutions to the

Read more...

Farmalider presents ECO, its new responsible innovation platform in healthcare for the pharmaceutical industry

abril 8, 2026

This B2B proposal integrates clean label formulations, sustainable packaging, and European quality standards without compromising scientific or regulatory rigor. Sustainability,

Read more...

Farmalider drives sustainable innovation with its new ECO platform

abril 8, 2026

This B2B proposal integrates clean label formulations, sustainable packaging, and European quality standards without compromising scientific or regulatory rigor. Sustainability,

Read more...

The Spanish project ThyTech is presented at the 8th Treg-Directed Therapies Summit 2026 in Boston

abril 7, 2026

Dr. Rafael Correa-Rocha, founder and Chief Scientific Officer (CSO) of ThyTech and researcher at the Gregorio Marañón Health Research Institute

Read more...

Farmalider: “The CIEGE Certificate is a tool that strengthens our credibility with clients, partners, and international organizations.”

marzo 11, 2026

Farmalider, S.A. receives the CIEGE Certificate from INFORMA – elEconomista for excellence in business management Farmalider is a pharmaceutical group

Read more...

8M, Women Breaking the Mold: Leadership Without Limits

marzo 10, 2026

Although they are still a minority in the ecosystem, more and more women are becoming entrepreneurs. They are daring to

Read more...

The ecological transition needs all the available talent

marzo 10, 2026

The ecological transition has ceased to be an aspiration and has become a criterion of competitiveness. Today, decarbonisation, sustainable finance,

Read more...

The Evolution Of Flu, Common Cold And The OTC Cough & Cold Market

enero 13, 2026

The evolution of flu and common cold: health impact and growth of the OTC Cough & Cold market Every winter,

Read more...

Farmalider Receives the 2025 CIEGE Certificate of Excellence in Business Management and Ranks Above the Average of Certified Companies

diciembre 2, 2025

The CIEGE Certificate, promoted by elEconomista.es and Informa D&B, is based on one of the most rigorous evaluations on the

Read more...

International Collaboration in Biotechnology and Pharmaceutical Innovation: Farmalider Welcomes the Shanghai Delegation

diciembre 2, 2025

Pharmaceutical innovation is global. Yesterday, we had the honor of welcoming the Shanghai Municipal Government Delegation to our Madrid offices,

Read more...
  • Legal Notice
  • Privacy policy
  • Ethical Channel
  • Contact
  • Legal Notice
  • Privacy policy
  • Ethical Channel
  • Contact
Farmacovigilancia

Farmalider© 2026

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Siempre activo
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Administrar opciones
  • Gestionar los servicios
  • Gestionar {vendor_count} proveedores
  • Leer más sobre estos propósitos
View preferences
  • {title}
  • {title}
  • {title}